Answers are grounded in this paper and cite their sources.
predicted enhanced metastatic potential and poor patient survival, it also rendered HER2-positive breast cancer cells more sensitive to glutaminase inhibition. The findings define a previously unknown mechanism of EphA2-mediated glutaminolysis through YAP/TAZ activation in HER2-positive breast cancer and identify potential therapeutic targets in patients.
No takes yet. Share an insight, caveat, or question.
Edwards et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: